These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7847877)

  • 1. Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Turin F; Faury P; Hantz O; Camplo M; Mourier N; Berthillon P; Graciet JC; Chermann JC; Trépo C
    Antiviral Res; 1994 Oct; 25(2):161-8. PubMed ID: 7847877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
    J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY
    Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.
    Mansour TS; Jin H; Wang W; Hooker EU; Ashman C; Cammack N; Salomon H; Belmonte AR; Wainberg MA
    J Med Chem; 1995 Jan; 38(1):1-4. PubMed ID: 7837220
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine.
    Severini A; Liu XY; Wilson JS; Tyrrell DL
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1430-5. PubMed ID: 7492080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
    Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
    Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
    Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
    Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective synthesis and antiviral activity of D-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides.
    Chong Y; Choo H; Choi Y; Mathew J; Schinazi RF; Chu CK
    J Med Chem; 2002 Oct; 45(22):4888-98. PubMed ID: 12383014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
    Chen X; Chen H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution and pharmacokinetics.
    Dusserre N; Lessard C; Paquette N; Perron S; Poulin L; Tremblay M; Beauchamp D; Désormeaux A; Bergeron MG
    AIDS; 1995 Aug; 9(8):833-41. PubMed ID: 7576316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV.
    Kini GD; Beadle JR; Xie H; Aldern KA; Richman DD; Hostetler KY
    Antiviral Res; 1997 Sep; 36(1):43-53. PubMed ID: 9330760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duck hepatitis B virus model for screening of antiviral agents from medicinal herbs.
    Mi Z; Chen H; Zhang X; Shao X; Li Z; Wu X
    Chin Med J (Engl); 1995 Sep; 108(9):660-4. PubMed ID: 8575230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
    Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral evaluation of SATE-foscarnet prodrugs and new foscarnet-AZT conjugates.
    Meier C; Aubertin AM; de Monte M; Faraj A; Sommadossi JP; Périgaud C; Imbach JL; Gosselin G
    Antivir Chem Chemother; 1998 Jan; 9(1):41-52. PubMed ID: 9875376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.
    Doong SL; Tsai CH; Schinazi RF; Liotta DC; Cheng YC
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8495-9. PubMed ID: 1656445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.